MUROMACHI CHEMICALS INC. Logo

MUROMACHI CHEMICALS INC.

A diversified manufacturer of pharmaceuticals, chemical systems, health foods & functional materials.

4885 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
大牟田市新勝立町一丁目38番5
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Muromachi Chemicals Inc. is a diversified manufacturer operating across four core business segments. The Pharmaceutical division produces and sells medical products and active pharmaceutical ingredients (APIs). The Chemical business specializes in high-performance, customized liquid treatment systems for various applications, including environmental solutions. The Consumer Healthcare division manufactures and markets health foods. Additionally, the Functional Materials segment supports customer development with a broad range of standard and custom-made products for diverse markets. Founded in 1917, the company leverages its long-standing expertise to develop and provide innovative solutions that contribute to health and society.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for MUROMACHI CHEMICALS INC. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-26 03:41
Regulatory News Service
確認書
Japanese 8.7 KB
2025-08-26 03:40
Annual Report
有価証券報告書-第79期(2024/06/01-2025/05/31)
Japanese 1020.4 KB
2025-01-14 08:01
Regulatory News Service
確認書
Japanese 8.7 KB
2025-01-14 08:00
Interim Report
半期報告書-第79期(2024/06/01-2025/05/31)
Japanese 214.1 KB
2024-09-04 03:00
Regulatory News Service
臨時報告書
Japanese 27.6 KB
2024-08-28 08:34
Regulatory News Service
内部統制報告書-第78期(2023/06/01-2024/05/31)
Japanese 22.8 KB
2024-08-28 08:32
Annual Report
有価証券報告書-第78期(2023/06/01-2024/05/31)
Japanese 986.7 KB
2024-08-28 08:32
Regulatory News Service
確認書
Japanese 8.7 KB
2024-04-12 09:01
Regulatory News Service
確認書
Japanese 8.7 KB
2024-04-12 09:01
Quarterly Report
四半期報告書-第78期第3四半期(2023/12/01-2024/02/29)
Japanese 178.7 KB
2024-01-12 08:02
Quarterly Report
四半期報告書-第78期第2四半期(2023/09/01-2023/11/30)
Japanese 213.9 KB
2024-01-12 08:02
Regulatory News Service
確認書
Japanese 8.7 KB
2023-10-13 09:02
Regulatory News Service
確認書
Japanese 8.7 KB
2023-10-13 09:01
Quarterly Report
四半期報告書-第78期第1四半期(2023/06/01-2023/08/31)
Japanese 182.3 KB
2023-08-29 03:35
Regulatory News Service
臨時報告書
Japanese 24.0 KB

Automate Your Workflow. Get a real-time feed of all MUROMACHI CHEMICALS INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for MUROMACHI CHEMICALS INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
BioGaia Logo
Develops and commercializes clinically proven probiotics for digestive health across all life stages.
Sweden BIOG
Bio-Gate AG Logo
Develops antimicrobial & antiviral tech for medical, cosmetic, & industrial products.
Germany BIG1
BioInvent International Logo
Develops first-in-class immuno-modulatory antibodies for cancer therapy.
Sweden BINV
BioLineRx Ltd. Logo
Biopharma firm developing and commercializing therapies for cancer and rare diseases.
Israel BLRX
BioMaxima S.A. Logo
Manufacturer of IVD solutions including tests, reagents, and equipment for medical labs.
Poland BMX
bioMérieux Logo
Provides in vitro diagnostic solutions for clinical and industrial microbiology.
France BIM
BioPorto Logo
IVD company developing NGAL biomarkers for early acute kidney injury (AKI) risk assessment.
Denmark BIOPOR
Biosergen AB Logo
Developing novel antifungal drugs for life-threatening infections in immunocompromised patients.
Sweden BIOSGN
Biosynex Logo
European manufacturer of rapid diagnostic tests for professionals and consumer self-tests.
France ALBIO
Biotest AG Logo
Develops plasma protein products & biotherapeutics for immunology, haematology & intensive care.
Germany BIO3

Talk to a Data Expert

Have a question? We'll get back to you promptly.